Catalent combines more than 80 years' manufacturing expertise, superior product quality and reliable supply, with a global network of facilities approved by 35 regulatory agencies, to provide flexible commercial and clinical manufacturing solutions. As a collaborator and innovative solution provider, the company has supported over half of all new molecular entities approved by the FDA in the last ten years.
Producing over 70 billion doses annually, Catalent provides manufacturing expertise for oral, sterile, biologic and inhaled dose forms for clients around the world. It has proven expertise in technology transfers and product launches, custom suite models, speciality handling (highly potent / DEA licenced compounds), and manufacturing technologies, leveraging its more than 30 global facilities with the capacity to support a wide range of small and large scale manufacturing requirements.
From a single, tailored solution, or multiple answers throughout a product's lifecycle, Catalent can improve the total value of treatments - from discovery to market.
Catalent. More products. Better treatments. Reliably supplied.™